- CRS Publications
- News
News
Authors:
Date:
Business Wire: July 19, 2016 – PRINCETON, NJ, U.S.A., and PARIS, France – STENTYS (Paris: STNT) (FR0010949404 — STNT), a medical technology company commercializing the world’s first and only Self-Apposing® coronary stent, today announced that it has commenced enrolling patients in the TRUNC trial,…
Authors:
Date:
Business Wire: July 14, 2016 – MONTGOMERY, TX, U.S.A. – AngioSoma, Inc. (OTCQB: SOAN), previously known as First Titan Corp. (the “company,” “we,” and “our”), changed our corporate name and focus to that of a clinical-stage biopharmaceutical company, introducing an exciting new treatment for one of…
Authors:
Date:
Business Wire: June 14, 2016 – WOBURN, MA, U.S.A. – Wolfe Laboratories today announced that Frank Tagliaferri, PhD, has been appointed vice president, pharmaceutical development, effective immediately. Dr. Tagliaferri will lead technical operations for Wolfe’s rapidly growing client base, bringing…
Authors:
Date:
Business Wire: June 9, 2016 – ARDSLEY, NY, U.S.A. – Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced pharmacokinetic (PK) data from a phase 1 study of CVT-427, an inhaled formulation of zolmitriptan, resulting in increased bioavailability and faster absorption compared to oral and nasal…
Authors:
Date:
Business Wire: June 6, 2016 – TORONTO, Canada – Highland Therapeutics Inc.’s wholly owned subsidiary, Ironshore Pharmaceuticals and Development, Inc. (“Ironshore”), today announced positive clinical data from the second phase 3 pivotal trial of its investigational drug product, HLD-200 (delayed-…
Authors:
Date:
Business Wire: May 26, 2016 – DUBLIN, OH, U.S.A. – Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) announced the receipt of an initial notice of award for a fast-track Small Business Innovation Research (SBIR) grant providing for up to $1.8 million from the National Institutes of Health’s (NIH’s…
